市場調查報告書
商品編碼
1287529
單細胞多組學市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測Single Cell Multiomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
全球單細胞多組學市場規模在2022年達到34億美元。展望未來,IMARC集團預計到2028年,市場規模將達到91億美元,在2023-2028年期間表現出17.6%的成長率(CAGR)。
單細胞多組學是指對單個細胞的多種類型的分子進行分析,以獲得有關細胞多樣性和異質性的洞察力。它包括單細胞基因組學、蛋白質組學、轉錄物組學和代謝組學,廣泛用於神經學、免疫學、細胞生物學和腫瘤學。單細胞多組學有助於加強對異質組織的群體結構和細胞特性的理解。它利用單細胞分離和分配技術來提供分子層和複雜生物結構的圖像。與傳統使用的活細胞螢光成像技術相比,單細胞多組學不包括破壞細胞進行分析,並能從一個細胞測量多種類型的分子。因此,它被廣泛用於整個生物技術和製藥組織、醫院、學術和研究機構以及診斷實驗室。
癌症和傳染性病毒疾病等慢性疾病的發病率上升,是推動市場成長的關鍵因素之一。單細胞多組學提供了腫瘤中細胞成分的高解析度景觀。此外,廣泛採用產品對細胞異質性、腫瘤微環境和抗體發展進行可視化和分析,有利於市場成長。此外,各種技術進步,如單細胞分離和條形碼技術的發展,使脫氧核糖核酸(DNA)、信使核糖核酸(mRNA)和蛋白質概況可以在單細胞解析度下測量,為市場成長提供推動力。與此相呼應,製藥業的大幅成長對市場成長產生了積極的影響。其他因素,包括擴大採用個性化醫療來治療遺傳性疾病,以及醫療基礎設施的廣泛改善,預計將推動市場的成長。
The global single cell multiomics market size reached US$ 3.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.1 Billion by 2028, exhibiting a growth rate (CAGR) of 17.6% during 2023-2028.
Single cell multiomics refers to the analysis of multiple types of molecules from an individual cell to gain insights regarding cellular diversity and heterogenity. It involves single cell genomics, proteomics, transcriptomics and metabolomics and is widely used in neurology, immunology, cell biology and oncology. Single cell multiomics aids in enhancing the understanding of population architectures and cellular properties of heterogeneous tissues. It utilizes single cell isolation and dispensing techniques to provide images of the molecular layers and complex biological structures. In comparison to the traditionally used live-cell fluorescence imaging techniques, single-cell multi-omics does not involve the destruction of cells for analysis and can measure multiple types of the molecule from a single cell. As a result, it is widely used across biotechnology and pharmaceutical organizations, hospitals, academics and research institutes and diagnostic laboratories.
The rising prevalence of chronic diseases, such as cancer and communicable viral diseases, is one of the key factors driving the growth of the market. Single cell multiomics provides a high-resolution landscape of cellular components in the tumors. Additionally, the widespread product adoption for visualization and analysis of cell heterogeneity, tumor micro-environment and antibody development are favoring the market growth. Moreover, various technological advancements, such as the development of single-cell isolation and barcoding technologies that enable deoxyribonucleic acid (DNA), messenger ribonucleic acid (mRNA) and protein profiles to be measured at a single-cell resolution, are providing a thrust to the market growth. In line with this, significant growth in the pharmaceutical industry is positively impacting the market growth. Other factors, including the increasing adoption of personalized medicine for the treatment of genetic disorders, along with the extensive improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global single cell multiomics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, product type, technique, application and end user.
Single Cell Genomics
Single Cell Proteomics
Single Cell Transcriptomics
Single Cell Metabolomics
Consumables
Instruments
Software
Single-Cell Isolation and Dispensing
Single-Cell Analysis
Oncology
Cell Biology
Neurology
Others
Academic Institutes
Contract Research Organizations
Pharmaceutical and Biotech Companies
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being 10x Genomics Inc., Becton Dickinson and Company, BGI Genomics (BGI Group), Bio-RAD Laboratories Inc., Fluidigm Corporation, Illumina Inc., Mission Bio, NanoCellect Biomedical, Nanostring Technologies Inc., Proteona, Takara Bio Inc. (Takara Holdings) and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
1. What was the size of the global single cell multiomics market in 2022?
2. What is the expected growth rate of the global single cell multiomics market during 2023-2028?
3. What has been the impact of COVID-19 on the global single cell multiomics market?
4. What are the key factors driving the global single cell multiomics market?
5. What is the breakup of the global single cell multiomics market based on the type?
6. What is the breakup of the global single cell multiomics market based on the product type?
7. What is the breakup of the global single cell multiomics market based on the technique?
8. What is the breakup of the global single cell multiomics market based on the application?
9. What is the breakup of the global single cell multiomics market based on the end user?
10. What are the key regions in the global single cell multiomics market?
11. Who are the key players/companies in the global single cell multiomics market?